Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compare: CT-P6 vs Herceptin in metastatic breast cancer
NCT01084876Phase 3Completed
- Sponsor
- Celltrion
- Start
- Jun 2010
- Primary completion
- Jul 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Celltrion. Started Jun 2010; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01084876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084876.